Cost-Effectiveness of SGLT2 Inhibitors in a Real-World Population: A MICADO Model-Based Analysis Using Routine Data from a GP Registry
暂无分享,去创建一个
G. Nijpels | J. Beulens | P. Elders | T. Feenstra | A. van Giessen | M. El Alili | Rudolf R Hoogenveen | S. Knies | Junfeng Wang | Xinyu Li